Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308012960> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4308012960 endingPage "58" @default.
- W4308012960 startingPage "52" @default.
- W4308012960 abstract "The study was aimed to determine the level of class G antibodies specific to Bp, Es, Pg (IgG-Bp, IgG-Es, IgG-Pg) in patients with colorectal and breast cancers. Material and methods. The content of these antibodies in the blood serum of healthy women (n=401), patients with colorectal cancer (n=219) and patients with breast cancer (n=1469) was studied using a non-competitive enzyme immunoassay. Statistical analysis of the results was performed using the Statistica 8.0 software. Results. The levels of IgG-Bp >7 and IgG-Es>6 were higher in patients with colorectal cancer than in healthy controls (66 % vs 25 %, p<0.0001, OR=5.9 and 58 % vs s 45 %, p=0.002, OR=1.7, respectively). The individual antibody ratios of IgG-Bp/IgG-Es >1, IgG-Bp/IgG-Pg>1.5, and IgG-Es/IgG-Pg>1.5 were also higher in patients with colorectal cancer than in healthy controls (74 % vs 34 %, p<0.0001, OR=5.6; 75 % vs 28 %, p<0.0001, and 58 % vs 38 %, p<0.0001, OR=2.3, respectively). Compared to healthy controls, breast cancer patients had higher values of IgG-Bp >6 (57 % vs 33 %, p<0.0001, OR=2.7) and IgG-Es>5 (62 % vs 53 %, p=0.003, or=1.4) and ratios of IgG-Bp/IgG-Es>1 (55 % vs 34 %, p<0.0001, or=2.4), IgG-Bp/IgG-Pg>1.3 (71 % vs 36 %, p<0.0001, or=4.5) and IgG-Es/IgG-Pg>1.4 (62 % vs 44 %, p<0.0001, or=2.1). Compared to breast cancer patients, colorectal cancer patients had higher values of IgG-Bp>7 (66 % vs 50 %, p<0.0001) and the ratios of igg-Bp/IgG-Es >1 (74 % vs 55 %, p<0.0001) and IgG-Bp/IgG-Pg>1.5 (76 % vs 60 %, p<0.0001). Conclusion. IgG-Bp, IgG-Es, and IgG-Pg immunoassay could serve as a screening tool to identify population at risk of colorectal and breast cancers." @default.
- W4308012960 created "2022-11-07" @default.
- W4308012960 creator A5002404805 @default.
- W4308012960 creator A5007315151 @default.
- W4308012960 creator A5047617052 @default.
- W4308012960 creator A5072290736 @default.
- W4308012960 creator A5079964609 @default.
- W4308012960 creator A5085220393 @default.
- W4308012960 date "2022-10-28" @default.
- W4308012960 modified "2023-09-26" @default.
- W4308012960 title "Class G antibodies specific for benzo[a]pyrene, estradiol and progesterone in women with colorectal cancer" @default.
- W4308012960 cites W1993224729 @default.
- W4308012960 cites W1998059659 @default.
- W4308012960 cites W2016965610 @default.
- W4308012960 cites W2033127393 @default.
- W4308012960 cites W2118187343 @default.
- W4308012960 cites W2121592661 @default.
- W4308012960 cites W2122673449 @default.
- W4308012960 cites W2145414062 @default.
- W4308012960 cites W2618930482 @default.
- W4308012960 cites W2903709126 @default.
- W4308012960 cites W2914768000 @default.
- W4308012960 cites W3034045203 @default.
- W4308012960 cites W3035571166 @default.
- W4308012960 doi "https://doi.org/10.21294/1814-4861-2022-21-5-52-58" @default.
- W4308012960 hasPublicationYear "2022" @default.
- W4308012960 type Work @default.
- W4308012960 citedByCount "0" @default.
- W4308012960 crossrefType "journal-article" @default.
- W4308012960 hasAuthorship W4308012960A5002404805 @default.
- W4308012960 hasAuthorship W4308012960A5007315151 @default.
- W4308012960 hasAuthorship W4308012960A5047617052 @default.
- W4308012960 hasAuthorship W4308012960A5072290736 @default.
- W4308012960 hasAuthorship W4308012960A5079964609 @default.
- W4308012960 hasAuthorship W4308012960A5085220393 @default.
- W4308012960 hasBestOaLocation W43080129601 @default.
- W4308012960 hasConcept C121608353 @default.
- W4308012960 hasConcept C126322002 @default.
- W4308012960 hasConcept C134018914 @default.
- W4308012960 hasConcept C159654299 @default.
- W4308012960 hasConcept C203014093 @default.
- W4308012960 hasConcept C2780420688 @default.
- W4308012960 hasConcept C2780898057 @default.
- W4308012960 hasConcept C526805850 @default.
- W4308012960 hasConcept C530470458 @default.
- W4308012960 hasConcept C71924100 @default.
- W4308012960 hasConceptScore W4308012960C121608353 @default.
- W4308012960 hasConceptScore W4308012960C126322002 @default.
- W4308012960 hasConceptScore W4308012960C134018914 @default.
- W4308012960 hasConceptScore W4308012960C159654299 @default.
- W4308012960 hasConceptScore W4308012960C203014093 @default.
- W4308012960 hasConceptScore W4308012960C2780420688 @default.
- W4308012960 hasConceptScore W4308012960C2780898057 @default.
- W4308012960 hasConceptScore W4308012960C526805850 @default.
- W4308012960 hasConceptScore W4308012960C530470458 @default.
- W4308012960 hasConceptScore W4308012960C71924100 @default.
- W4308012960 hasIssue "5" @default.
- W4308012960 hasLocation W43080129601 @default.
- W4308012960 hasOpenAccess W4308012960 @default.
- W4308012960 hasPrimaryLocation W43080129601 @default.
- W4308012960 hasRelatedWork W1577500882 @default.
- W4308012960 hasRelatedWork W1829122917 @default.
- W4308012960 hasRelatedWork W1966504330 @default.
- W4308012960 hasRelatedWork W1979139803 @default.
- W4308012960 hasRelatedWork W2020117355 @default.
- W4308012960 hasRelatedWork W2030805283 @default.
- W4308012960 hasRelatedWork W2037631372 @default.
- W4308012960 hasRelatedWork W2045985401 @default.
- W4308012960 hasRelatedWork W2079937358 @default.
- W4308012960 hasRelatedWork W2748952813 @default.
- W4308012960 hasVolume "21" @default.
- W4308012960 isParatext "false" @default.
- W4308012960 isRetracted "false" @default.
- W4308012960 workType "article" @default.